abstract |
The present invention relates to novel therapeutic agents that are safe and effective Janus kinase 1 inhibitors, as well as pharmaceutical compositions and methods thereof and various diseases and disorders (eg, inflammatory diseases, immune-mediated diseases, or cancers). Provides use in treatment. [Selection diagram] None |